Site-selective 8-Cl-cAMP which causes growth inhibition and differentiation increases DNA (CRE)-binding activity in cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/2528474

FEBS Lett. 1989 Aug 28 254 1-2 83-8

Download in:

View as

General Info

PMID
2528474